Three independent discounted-cash-flow-style models value Nutex Health Inc. Common Stock every trading day. 0 of 3 currently price NUTX above its market price.
| Free Cash Flow model | $-3,206.34 |
| Excess Profit model | $-2,680.97 |
| Residual Earnings model | $-5.53 |
| Dividend Discount model | — |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +32.7% |
| Net debt / EBITDA | 0.6× |
| Gross margin | +50.8% |
| Revenue CAGR | +58.6% |
| Cash conversion | 1.4× |
| Dividend yield | — |
| Buyback yield | -25.0% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open NUTX in StockKitty